文献速递产科母胎医学

在高容量三级医疗中心实施产前晚期早产儿皮质类固醇方案

Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-12-17

这项回顾性队列研究评估了某三级医疗中心实施产前晚期早产儿皮质类固醇方案后的依从性及新生儿结局。方案实施后81.2%的产妇接受了依从性治疗,但新生儿在出生后24小时内血糖<50 mg/dL的几率显著增加(aOR 1.37, 95%CI 1.05-1.80),呼吸结局无显著改善。

要点

  • 实施产前晚期早产儿皮质类固醇方案后,81.2%的产妇接受了依从性治疗。
  • 与历史对照相比,方案实施后新生儿低血糖(<50 mg/dL)几率增加(aOR 1.37)。
  • 呼吸系统疾病发病率或其他新生儿结局无显著差异。

核心结论

  • 新机构方案被快速采纳,但与历史对照相比,暴露于产前晚期早产儿皮质类固醇的新生儿低血糖几率增加,呼吸疾病发病率无显著改善。

研究设计与样本

  • 回顾性队列研究,纳入2012年11月至2013年10月(方案前)及2016年4月至2017年3月(方案后)收治的34至36 5/7周单胎妊娠产妇,方案前队列452人,方案后队列451人。

主要发现

  • 方案后队列中81.2%(366/451)的产妇接受了依从性治疗。
  • 与方案前队列相比,方案后队列新生儿出生后24小时内血糖<50 mg/dL的几率显著更高(aOR 1.37,95%CI 1.05-1.80)。
  • 限制于接受依从性治疗的方案后产妇时,结果相似(血糖<50 mg/dL:aOR 1.52,95%CI 1.14-2.03)。
  • 复合呼吸疾病发病率或其他新生儿结局无差异。

关键数值与推荐

  • 方案推荐对34至36 5/7周妊娠、有早产风险且未接受过皮质类固醇的产妇给予皮质类固醇。
  • 排除胎儿畸形或孕前或妊娠期糖尿病产妇。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since publication of the sentinel antenatal late preterm steroids clinical trial, the use of antenatal steroids has become a routine aspect of the management of pregnancies at risk for late preterm delivery. However, in practice, the administration of antenatal corticosteroids in the late preterm period is widely varied across provider and institution, and the process of implementation of this new practice as well as outcomes associated with implementation are not well understood. OBJECTIVE: The objective was to evaluate institutional adherence to an antenatal late preterm corticosteroid protocol and to assess neonatal outcomes associated with its introduction. STUDY DESIGN: This is a retrospective cohort study of all women with singleton pregnancies admitted between 34 to 36 5/7 weeks who presented in the year before ("pre-protocol": November 2012 to October 2013) and after implementation ("post-protocol": April 2016 to March 2017). The protocol recommends corticosteroid administration to women 34 to 36 5/7 weeks gestation at risk for preterm birth who have not received prior corticosteroids. Women with fetal anomalies or pregestational or gestational diabetes were excluded from analysis. The frequency with which eligible women received corticosteroids and ineligible women were appropriately excluded (adherence) was calculated on a monthly basis. Neonatal outcomes of interest were hypoglycemia, receipt of dextrose, birth weight, 5 minute Apgar less than 7, receipt of surfactant, respiratory distress syndrome, transient tachypnea of the newborn, neonatal intensive care unit length of stay, intraventricular hemorrhage, necrotizing enterocolitis, culture positive sepsis, bronchopulmonary dysplasia, and death. Bivariable and multivariable analyses were used to compare neonatal outcomes between 1) all women in the post-protocol cohort to those in the pre-protocol cohort and 2) only women who received adherent care in the post-protocol cohort to all women in the pre-protocol cohort. RESULTS: A total of 452 women were included in the pre-protocol cohort and 451 in the post-protocol cohort. The majority of the post-protocol women (N=366, 81.2%) received adherent care. Women in both cohorts were similar with the exception that women in the post-protocol cohort were more likely to be nulliparous (p=0.013). Compared to the pre-protocol period, neonates of women in the post-protocol period had significantly higher odds of hypoglycemia <50 mg/dL in the first 24 hours of life (aOR 1.37, 95% CI 1.05-1.80), without improvements in respiratory outcomes. Results were similar when restricting the analysis to only women in the post-protocol cohort who received care adherent care (glucose <50 mg/dL: aOR 1.52, 95% CI 1.14-2.03). No differences in composite respiratory morbidity or other neonatal outcomes were observed. CONCLUSION: Uptake of a new institutional protocol for antenatal late preterm corticosteroids was rapid. Compared with historic controls, neonates exposed to antenatal late preterm corticosteroid experienced increased odds of hypoglycemia, without significant improvements in respiratory morbidities.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Badreldin N, Willert GG, Henricks AA, et al. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center. Am J Obstet Gynecol MFM. 2019. PMID: 32944712. doi:10.1016/j.ajogmf.2019.100076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。